Cancer’s Grip May Be Loosened by Tampering with DNA Clamp

A rationally designed drug-like protein interferes with the protein-protein interactions of PCNA, the so-called DNA clamp, offering a new way of hindering DNA replication in fast-proliferating cancer cells.

Charles River Labs Acquires KWS BioTest

Deal expands CRO’s discovery services offerings in oncology and immunology.

Novel Method Allows Researchers to Precisely Engineer and Monitor Protein Function

New technology incorporates a range of useful non-canonical amino acids into proteins made in eukaryotes.

Sweet 16 Top Cancer Immunotherapy Developers

Immunotherapies for cancer have emerged in recent years as a “sweet spot” among researchers, companies, investors, and especially, patients.

Harvard Team Takes Major Step toward Overcoming Antibiotic Resistance

Novel platform for antibiotic discovery looks to overcome problem of antibiotic resistance

Immunocompromised Patients Could Get Help from New Vaccine Strategy

Bolstering the immune system is not a new strategy when trying to protect against deadly pathogens, yet for those individuals that are immunocompromised, this...

Cell Therapeutics to Appeal FDA Decision on Pixantrone NDA

Agency had asked that an additional clinical study be conducted in relapsed/refractory aggressive NHL.

Roche Inks Up-to-$409M Cancer Immunotherapy Alliance with Pieris

Partners will develop new drug candidates based on Pieris’ Anticalin® technology platform against an undisclosed target.

Recently Featured

Stay Connected

Scroll Up